Loading company…
Yuyan Pharmaceutic develops medical aesthetic products, including a recombinant botulinum toxin protein.
Yuyan Pharmaceutic researches and develops medical aesthetic products, including YY001, a recombinant A-type botulinum toxin protein. The company is based in Chongqing, China, and was established in 2020 as part of Guangzhou Inming Biomedical. In November 2023, it entered an exclusive distribution agreement with investor Huadong Medicine for YY001 in medical aesthetics in mainland China, Hong Kong and Macao, and closed a venture funding round.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in